Day

1. If the patient is being treated with UFH, remeasure the aPTT, and adjust dose if necessary. If patient is being treated with LMWH or fondaparinux, continue therapy.

2. Interview the patient to determine if there is worsening or new symptoms related to VTE. Ask the patient about overt bruising or bleeding, particularly at the injection site, as well as changes in stool or urine color.

3. Advise the patient to limit physical activity if pain persists and to elevate the extremity; increase activity as tolerated.

4. Document activities in medical record.

Your Heart and Nutrition

Your Heart and Nutrition

Prevention is better than a cure. Learn how to cherish your heart by taking the necessary means to keep it pumping healthily and steadily through your life.

Get My Free Ebook


Post a comment